| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |